• Discovery
    Driving the discovery and development of microbiome-based treatments to improve human health
    Therapeutic Platform
    Discovering therapeutic leads for major chronic diseases with a human-first, data-driven approach
    Analysis Platform
    World-leading technology to analyse the gut microbiome with unparalleled accuracy

    DATA-DRIVEN DISCOVERY

    “Microba has an incredible dataset to develop treatments for chronic diseases that will really make a difference for patients”
    A/Prof Lutz Krause Chief Scientific Officer
  • Services
    Powering microbiome discovery and the development of new health solutions
    Research Services
    Providing researchers with precise and comprehensive microbiome analysis and project support
    Global Testing Solutions
    Providing evidence-based, actionable information for healthcare practitioners and individuals

    ADVANCING KNOWLEDGE

    “Microba empowers researchers, clinicians, and individuals to understand and influence the gut microbiome to improve human health.”
    Luke Reid Chief Executive Officer
  • Company
    Leadership team
    Combining microbiome and drug discovery expertise to address chronic disease
    Publications
    Advancing microbiome science to reveal new relationships to health
    Latest news
    Read about Microba’s progress, partnership news and latest discoveries

    DRIVEN TO DISCOVER

    “Microba continues to push the boundaries of the known gut microbiome and will remain at the forefront of analysis and discovery.”
    Professor Gene Tyson Co-founder
Back to Announcements

Evaluation of the Microba Community Profiler (MCP) for taxonomic profiling of metagenomic datasets from the human gut microbiome

A fundamental goal of microbial ecology is to accurately determine the species composition in a given microbial ecosystem. In the context of the human microbiome, this is important for establishing links between
microbial species and disease states.